PLRZ
Polyrizon Ltd. NASDAQ Listed Oct 29, 2024$14.14
Mkt Cap $15.8M
52w Low $2.88
1.1% of range
52w High $1053.00
50d MA $13.32
200d MA $9.80
P/E (TTM)
-7.7x
EV/EBITDA
-2.1x
P/B
1.2x
Debt/Equity
0.0x
ROE
-15.9%
P/FCF
-3.0x
RSI (14)
—
ATR (14)
—
Beta
-4.55
50d MA
$13.32
200d MA
$9.80
Avg Volume
51.8K
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
5 Ha-Tidhar Street · Ra'anana 4366507 · IL
Data updated apr 26, 2026 7:58pm
· Source: massive.com